{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T15:04:03Z","timestamp":1779807843555,"version":"3.53.1"},"reference-count":28,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CLEP"],"DOI":"10.2147\/clep.s615866","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T14:25:15Z","timestamp":1779805515000},"page":"1-11","source":"Crossref","is-referenced-by-count":0,"title":["Real-World Incidence and Management of Non-Immune Effector Cell-Associated Neurotoxicity Syndrome Neurologic Events Following Ciltacabtagene Autoleucel in Multiple Myeloma"],"prefix":"10.2147","volume":"Volume 18","author":[{"given":"Doris","family":"Hansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0423-5870","authenticated-orcid":true,"given":"Omar","family":"Castaneda Puglianini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Grajales-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Nagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabyasachi","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Alegria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"De Braganca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Lengil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukta","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Perciavalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Maitland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0060-765X","authenticated-orcid":true,"given":"Bruno","family":"Emond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Bixby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaina","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murali","family":"Janakiram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"17046","DOI":"10.1038\/nrdp.2017.46","volume":"3","author":"Kumar","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.1182\/blood-2010-10-299487","volume":"117","author":"Rajkumar","year":"2011","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41417-024-00750-2","volume":"31","author":"Sheykhhasan","year":"2024","journal-title":"Cancer Gene Ther"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2147\/CMAR.S510408","volume":"17","author":"Goel","year":"2025","journal-title":"Cancer Manag Res"},{"key":"ref5","unstructured":"US Food & Drug Administration. FDA approves ciltacabtagene autoleucel for relapsed or refractory multiple myeloma. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-ciltacabtagene-autoleucel-relapsed-or-refractory-multiple-myeloma. Accessed January 9, 2026."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S0140-6736(21)00933-8","volume":"398","author":"Berdeja","year":"2021","journal-title":"Lancet"},{"key":"ref7","first-page":"1","volume":"41","author":"Lin","year":"2023","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1200\/JCO-25-00760","volume":"43","author":"Jagannath","year":"2025","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1056\/NEJMoa2303379","volume":"389","author":"San-Miguel","year":"2023","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S1470-2045(25)00653-9","volume":"27","author":"Einsele","year":"2026","journal-title":"Lancet Oncol"},{"key":"ref11","unstructured":"US Food & Drug Administration. CARVYKTI. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/cellular-gene-therapy-products\/carvykti. Accessed April 1, 2026."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1200\/JCO.21.01992","volume":"39","author":"Santomasso","year":"2021","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1016\/S1470-2045(24)00715-0","volume":"26","author":"Graham","year":"2025","journal-title":"Lancet Oncol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.6004\/jadpro.2025.16.7.6","author":"Ow","year":"2025","journal-title":"J Adv Pract Oncol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1182\/blood.2024025945","volume":"145","author":"Sidana","year":"2025","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-025-01441-3","author":"Lim","year":"2025","journal-title":"Blood Cancer J"},{"key":"ref17","unstructured":"Janssen Biotech I. CARVYKTI\u00ae (ciltacabtagene autoleucel) prescribing information. Available from: https:\/\/www.janssenlabels.com\/package-insert\/product-monograph\/prescribing-information\/CARVYKTI-pi.pdf. Accessed January 9, 2026."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"6262","DOI":"10.1182\/blood-2025-6262","volume":"146","author":"Nishihori","year":"2025","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-026-01496-w","author":"Hansen","year":"2026","journal-title":"Blood Cancer J"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41591-025-04121-8","volume":"32","author":"Ho","year":"2026","journal-title":"Nat Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1182\/blood-2025-96","volume":"146","author":"Hosoya","year":"2025","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/jnnp-2024-333924","volume":"96","author":"Vonberg","year":"2025","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1182\/blood-2025-4586","volume":"146","author":"Rana","year":"2025","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1182\/blood-2025-1034","volume":"146","author":"Sidana","year":"2025","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"4144","DOI":"10.1182\/blood-2025-4144","volume":"146","author":"Zhu","year":"2025","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1749587","DOI":"10.3389\/fimmu.2026.1749587","volume":"17","author":"Schroeder","year":"2026","journal-title":"Front Immunol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1182\/blood.2023020571","volume":"142","author":"Karschnia","year":"2023","journal-title":"Blood"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1704826","DOI":"10.3389\/fneur.2025.1704826","volume":"16","author":"Kilroe","year":"2025","journal-title":"Front Neurol"}],"container-title":["Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/115658","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/115658","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T14:25:20Z","timestamp":1779805520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/real-world-incidence-and-management-of-non-immune-effector-cell-associ-peer-reviewed-fulltext-article-CLEP"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":28,"URL":"https:\/\/doi.org\/10.2147\/clep.s615866","relation":{},"ISSN":["1179-1349"],"issn-type":[{"value":"1179-1349","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}